Accuray Incorporated (ARAY)
$0.18-5.26%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $21M
- Beta
- 1.42
- P/E (TTM)
- -0.44
- Short % float
- 6.54%
- Days to cover
- 1.0
- SI change
- +49.6%
- 1W
- -28.00%
- 1M
- -21.74%
- vs SPY 1W
- -27.86%
- vs SPY 1M
- -24.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 26
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-59.4%
REV YoY-
ROE-4.7%
EPS YoY-
ROA-11.1%
GROSS28
OP-7
NET-12
[VALUATION]
P/E TTM-0.44
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B0.51
P/FCF-
EV/EBITDA-25.63
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E440.96
ALTMAN Z-
CURR RATIO1.50
ND/EBITDA-
BETA1.42
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on ARAY?
- LOPJLB’s latest quantitative signal on Accuray Incorporated (ARAY) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ARAY in?
- Accuray Incorporated (ARAY) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Accuray Incorporated (ARAY) do?
- Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a s…